Humana Inc. HUM
433.74 USD +21.95 (+5.33%)
At closeNov 6, 2026, 6:17 PM EST
432.88 -0.86 -0.20%
After hours · Nov 6, 6:17 PM ET
411.56 Day range 444.00
163.67 52-week range 433.74
- YTD
- +69.34%
- 1 year
- +72.73%
News
benzinga.com Humana Stock Rises After Narrower-Than-Expected Loss, Raised 2026 Profit Outlook Humana posted a narrower-than-expected third-quarter adjusted loss of 70 cents per share on revenue of $41.16 billion, above estimates, and raised its 2026 adjusted EPS guidance to at least $9.50.…
benzinga.com Humana Q3 2026 Earnings Call Transcript Humana (NYSE:HUM) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Humana (HUM) Reports Q3 Loss, Beats Revenue Estimates Humana (HUM) came out with a quarterly loss of $0.7 per share versus the Zacks Consensus Estimate of a loss of $1.03. This compares to earnings of $3.24 per share a year ago.
wsj.com Humana Lifts Outlook as Quarterly Revenue Jumps Humana raised its full-year earnings outlook as consolidated income and revenue rose in the recent quarter.
businesswire.com Humana Reports Third Quarter 2026 Financial Results; Raises Full Year 2026 Adjusted EPS Guidance LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share for the quarter ended September 30, 2026 (3Q26) versus the quarter…
benzinga.com Humana Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Humana Inc. (NYSE:HUM) will release its third-quarter earnings report before the opening bell on Friday, Nov. 6.- benzinga.com Humana Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Humana expects a Q3 loss of $1/share on $40.89B revenue; declared an 88.5-cent dividend as analysts raised price targets.
benzinga.com Nasdaq Tumbles 5.5% as AI Stocks Crater: Investor Sentiment Weakens, Fear & Greed Index Moves to ‘Extreme Fear’ Zone Markets plunged as AI stocks rout deepened, pushing CNN’s Fear & Greed Index to Extreme Fear; Nasdaq fell 5.5%, while AMD and Micron dropped 17%.
benzinga.com Airbnb, Charter Communications and 3 Stocks to Watch Heading Into Friday Charter, Humana and Fluor report earnings; Microchip beat estimates but cut guidance, while Airbnb topped forecasts and surged 11%.
benzinga.com Stock Market: Will S&P 500 Open Up or Down Today? Will the S&P 500 open higher? Polymarket odds hit 62% as Wall Street eyes jobs data and a tech rebound.
benzinga.com Enbridge, Moderna On Deck Friday As Demand, Vaccine Pipeline Face Test Enbridge headlines Friday’s reports, with investors weighing whether resilient pipeline utilization can offset a softer revenue comparison. Moderna, Brookfield Asset Management, Humana, Vistra, PPL,…
benzinga.com 3 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
zacks.com Can Higher Premiums Help Humana Beat Q3 Earnings Estimates? HUM's Q3 premiums are expected to rise 26%, boosting its chances of an earnings beat even as higher operating costs and a worsening benefits expense ratio loom.
247wallst.com Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch One stock has soared more than sevenfold this year, another just lost a quarter of its value on leaked data, and a third carries the fate of millions of retirees. Friday's earnings could test each…
benzinga.com How To Earn $500 A Month From Humana Stock Ahead Of Q3 Earnings Humana Inc. (NYSE:HUM) investors may be eyeing potential dividend gains ahead of the company's third-quarter earnings report on Friday, Nov. 6.
zacks.com Are Investors Undervaluing Humana (HUM) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
benzinga.com If You Invested $1000 In Humana Stock 20 Years Ago, You Would Have This Much Today Humana (NYSE:HUM) has outperformed the market over the past 20 years by 2.11% on an annualized basis producing an average annual return of 10.96%. Currently, Humana has a market capitalization of…
benzinga.com Humana And athenahealth Expand Electronic Prior Authorization Capabilities Across athenahealth’s Network Of 180K+ Physicians And Clinicians The collaboration supports Humana’s broader strategy to help patients access care more quickly by requiring prior authorization less often and making it simpler, faster and more connected when it is…
businesswire.com Humana and athenahealth expand electronic prior authorization capabilities nationwide, reducing administrative burden for physicians and helping patients access care faster BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and athenahealth today announced an expansion of electronic prior authorization capabilities across athenahealth's nationwide network of more than…
zacks.com Why Humana (HUM) Could Beat Earnings Estimates Again Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
benzinga.com QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins UnitedHealth expects Medicaid margins to bottom in 2026 and improve through 2028, UnitedHealthcare CEO Tim Noel says on earnings call.
benzinga.com Humana To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Tuesday Analysts cut targets for Duke, Hyatt, Pershing Square, Carlisle, Upstart, Arch Capital and Meta; raised VF, Rexford and SentinelOne.
benzinga.com Mizuho Maintains Outperform on Humana, Raises Price Target to $495 Mizuho analyst Ann Hynes maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $468 to $495.- benzinga.com Humana Forms JV With BlackRock To Manage And Operate Existing Network Of CenterWell Senior Primary Care Clinics; Reaffirms FY26 Adjusted EPS Guidance Humana Inc. (the "Company") issued a press release today reporting its entry into a new joint venture arrangement with funds and accounts managed by HPS Investment Partners, a subsidiary of…
benzinga.com Truist Securities Maintains Hold on Humana, Raises Price Target to $475 Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the price target from $415 to $475.
benzinga.com Oppenheimer Maintains Outperform on Humana, Raises Price Target to $525 Oppenheimer analyst Michael Wiederhorn maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $475 to $525.
benzinga.com DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test Humana includes DataMeds AI's Helomics ChemoFx assay in its Medicaid policy for gynecologic cancers, expanding payer reimbursement.
benzinga.com Raymond James Upgrades Humana to Outperform, Announces $520 Price Target Raymond James analyst John Ransom upgrades Humana (NYSE:HUM) from Market Perform to Outperform and announces $520 price target.
benzinga.com Dow Jumps Over 400 Points, Records Weekly Gain: Investor Sentiment Improves, Fear & Greed Index Moves yo ‘Neutral’ Zone CNN Fear & Greed Index rose to Neutral at 45 as U.S. stocks gained Friday; Dow jumped 423 points, while consumer sentiment weakened.
benzinga.com Stock Market Today: Nasdaq 100 Rebounds From OpenAI Scare, T-Mobile Tumbles 12% The Nasdaq 100 recovers from Thursday's OpenAI-driven selloff while T-Mobile sinks 12% on SpaceX's spectrum deal and the 10-year yield holds near 5.26%.
benzinga.com Gold Rises Over 1%; US Consumer Sentiment Falls U.S. stocks rose Friday, led by the Dow and Nasdaq; sentiment hit a five-month low, while Veea and WF Holding surged and T-Mobile fell.
benzinga.com Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday U.S. stocks rose Friday; Humana jumped 12.3% after improved 2027 Medicare Advantage ratings and reaffirmed FY26 EPS guidance.
benzinga.com Barclays Maintains Overweight on Humana, Raises Price Target to $582 Barclays analyst Andrew Mok maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $515 to $582.- benzinga.com Oppenheimer Maintains Outperform on Humana, Raises Price Target to $475 Oppenheimer analyst Michael Wiederhorn maintains Humana (NYSE:HUM) with a Outperform and raises the price target from $405 to $475.
benzinga.com Humana Stock Hits 52-Week High After Medicare Ratings Boost Humana’s 2027 Medicare Advantage Star Ratings jump, with 95% of members in 4+ star plans. HUM shares surge in premarket trading.
benzinga.com Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Scott Bessent Says US Is Starving Iran's 'Tyrannical Regime'— PKE, HUM, RENX in Focus (UPDATED) U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's mixed close.
benzinga.com CrowdStrike To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday Analysts raised targets for HOOD, SAIL, U and CRWD; cut targets for BULL, ALGN and PCRX, with PCRX downgraded to Neutral.- benzinga.com This Humana Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday Analysts upgraded Humana, Cboe, Jack Henry, Fastly, raising ratings and targets, including HUM to $596 and CBOE to $358.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session Gainers Humana (NYSE:HUM) stock moved upwards by 16.2% to $450.0 during Friday's pre-market session. The market value of their outstanding shares is at $46.4 billion. XORTX Therapeutics (NASDAQ:XRTX)…- benzinga.com Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To Shareholders Humana affirms its guidance of at least $9.00 in adjusted earnings per common share ("Adjusted EPS"), for the year ending December 31, 2026 ("FY 2026"). This guidance is consistent with the guidance
- benzinga.com Baird Upgrades Humana to Outperform, Raises Price Target to $596 Baird analyst Michael Ha upgrades Humana (NYSE:HUM) from Neutral to Outperform and raises the price target from $390 to $596.
benzinga.com Why Veea Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket Veea jumps 34% after regaining Nasdaq compliance; Freight Technologies leads gainers, while Alignment Healthcare plunges 24% among premarket losers.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers SCWorx Corp. - Common Stock (NASDAQ:WORX) shares moved upwards by 48.8% to $6.25 during Thursday's after-market session. XORTX Therapeutics (NASDAQ:XRTX) stock increased by 22.7% to $2.27.…
benzinga.com This NetApp Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday Analysts upgraded NetApp, Humana, Corteva, Afya, with price-target changes for four stocks.
benzinga.com Micron To Rally Around 187%? Here Are 10 Top Analyst Forecasts For Wednesday Wall Street analysts revised targets: upgrades for NetApp and Humana; downgrades for PJT Partners; mixed target changes for Redwood, Marvell, Yum and S&P
benzinga.com Cantor Fitzgerald Upgrades Humana to Overweight, Raises Price Target to $460 Cantor Fitzgerald analyst Sarah James upgrades Humana (NYSE:HUM) from Neutral to Overweight and raises the price target from $300 to $460.- benzinga.com Humana To Offer 2027 Medicare Advantage Plans With Continued Access To The Benefits, Including $0 Cost-Sharing On In-Network Primary Care Visits And Labs Plus Dental, Vision, And Hearing From October 15 Additional 2027 highlights include:Medicare Advantage plans in approximately 2,600 counties across 45 states and Washington, D.C., representing more than 80% of U.S. counties.Expanded Chronic…
benzinga.com This 3M Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday Analysts upgraded First Financial, 3M, Synopsys, Humana and Stem, raising targets for four while maintaining Stem’s $7 target.
benzinga.com Barclays Upgrades Humana to Overweight, Raises Price Target to $515 Barclays analyst Andrew Mok upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $407 to $515.
benzinga.com Akamai, Atlas Energy Solutions, People And Other Big Stocks Moving Higher On Friday U.S. stocks rose Friday; Akamai jumped 8.1% on an $11.6B Anthropic cloud deal, while Atlas Energy, Almonty and others posted strong gains.